Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy

Sarcina, Cristina; Tinelli, Carmine; Ferrario, Francesca; Visciano, Bianca; Pani, Antonello; De Silvestri, Annalisa; De Simone, Ilaria; Del Vecchio, Lucia; Terraneo, Veronica; Furiani, Silvia; Santagostino, Gaia; Corghi, Enzo; Pozzi, Claudio
July 2016
PLoS ONE;7/14/2016, Vol. 11 Issue 7, p1
Academic Journal
The clinical course of IgA nephropathy (IgAN) and its outcome are extremely variable. Proteinuria at baseline has been considered one of the most important risk factors. More recently, mean proteinuria of follow-up (time-average proteinuria: TAp) was described as a stronger marker of renal survival, suggesting to consider it as a marker of disease activity and response to treatment. We evaluated predictors of renal survival in IgAN patients with different degrees of renal dysfunction and histological lesions, focusing on the role of the therapy in influencing TAp. We performed a retrospective analysis of three prospective, randomized, clinical trials enrolling 325 IgAN patients from 1989 to 2005. Patients were divided into 5 categories according to TAp. The primary endpoint of the 100% increase of serum creatinine occurred in 54 patients (16.6%) and renal survival was much better in groups having lower TAp. The median follow up was 66.6 months (range 12 to 144). The primary endpoint of the 100% increase of serum creatinine occurred in 54 patients (16,6%) and renal survival was much better in groups having lower TA proteinuria. At univariate analysis plasma creatinine and 24h proteinuria, systolic (SBP) and diastolic (DBP) blood pressure during follow-up and treatment with either steroid (CS) or steroid plus azathioprine (CS+A) were the main factors associated with lower TAp and renal survival. At multivariate analysis, female gender, treatment with S or S+A, lower baseline proteinuria and SBP during follow-up remained as the only variables independently influencing TAp. In conclusion, TA-proteinuria is confirmed as one of the best outcome indicators, also in patients with a severe renal insufficiency. A 6-month course of corticosteroids seems the most effective therapy to reduce TAp.


Related Articles

  • Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0?g/day. Suzuki, Takayuki; Yamamoto, Tatsuo; Ohura, Masaharu; Fujigaki, Yoshihide; Yonemura, Katsuhiko; Kimura, Masato; Hishida, Akira // Clinical & Experimental Nephrology;Sep2004, Vol. 8 Issue 3, p243 

    Background. We investigated the clinical and pathological findings relevant to the efficacy of corticosteroid treatment in IgA nephropathy patients with 0.5 to 2.0 g/day of proteinuria at the initiation of corticosteroid treatment. Methods. In 27 IgA nephropathy patients who received 2-year...

  • Corticosteroid for IgA Nephropathy: Are They Really Therapeutic? Lin, Yujia; Jia, Junya; Guo, Yipeng; He, Dandan; Zhang, Yaru; Wang, Fuzhen; Yan, Tiekun; Liu, Youxia; Lin, Shan // American Journal of Nephrology;Jul2018, Vol. 47 Issue 6, p385 

    Background: IgA nephropathy (IgAN) is a common chronic glomerular disease that, in most patients, slowly progresses to end-stage kidney disease. The therapy with corticosteroid in IgAN is still a worldwide problem that is confusing the clinicians.Methods: MEDLINE,...

  • Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria. Uzu, Takashi; Harada, Tamaki; Ko, Mie; Yamato, Masafumi; Takahara, Ken; Yamauchi, Atsushi // Clinical & Experimental Nephrology;Sep2003, Vol. 7 Issue 3, p210 

    Background. In patients with heavy proteinuria, corticosteroid therapy has been shown to have favorable effects on the progression of IgA nephropathy. However, the efficacy of corticosteroids on the progression of IgA nephropathy with moderate proteinuria is still controversial. Methods. We...

  • Long-term prognosis of clinically early IgA nephropathy is not always favorable. Hajeong Lee; Jin Ho Hwang; Jin Ho Paik; Hyun Jin Ryu; Dong-Ki Kim; Ho Jun Chin; Yun Kyu Oh; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee // BMC Nephrology;2014, Vol. 15 Issue 1, preceding p1 

    Background The long-term prognosis of clinically early IgA nephropathy (IgAN) patients remains to be clarified. We investigated the long-term outcomes of IgAN patients with an apparently benign presentation and evaluated prognostic factors for renal survival. Methods We included patients with...

  • Microscopic papillary tumor in a renal needle biopsy specimen for IgA nephropathy. Isoshita, Rieko; Usui, Jo-ichi; Uesugi, Noriko; Nagata, Michio; Yamagata, Kunihiro // NDT Plus;Oct2011 Supplement 5, Vol. 4 Issue 5, p357 

    No abstract available.

  • Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function. Moriyama, Takahito; Nakayama, Kayu; Ochi, Ayami; Amemiya, Nobuyuki; Tsuruta, Yuki; Kojima, Chiari; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Nitta, Kosaku // Clinical & Experimental Nephrology;Apr2012, Vol. 16 Issue 2, p231 

    Background: The adaptation of steroid therapy and the effect of renin-angiotensin-aldosterone system inhibitors (RASIs) for advanced immunoglobulin A nephropathy (IgAN) patients with impaired renal function are still controversial. Methods: We divided 63 IgAN patients with an estimated...

  • How early renal biopsy has to be performed in children with isolated asymptomatic proteinuria? Coppo, Rosanna // Nephrology Dialysis Transplantation;Aug2012, Vol. 27 Issue 8, p3016 

    No abstract available.

  • Renal biopsy criterion in children with asymptomatic constant isolated proteinuria. Hama, Taketsugu; Nakanishi, Koichi; Shima, Yuko; Mukaiyama, Hironobu; Togawa, Hiroko; Tanaka, Ryojiro; Hamahira, Kiyoshi; Kaito, Hiroshi; Iijima, Kazumoto; Yoshikawa, Norishige // Nephrology Dialysis Transplantation;Aug2012, Vol. 27 Issue 8, p3186 

    …in several European countries children often perform urine analysis before entering intensive sport programs or by chance as routine analysis before minor surgery or for other health problems. In these cases the detection of isolated proteinuria and/or hematuria leads the Pediatricians...

  • Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy. Nam, Ki Heon; Kie, Jeong Hae; Lee, Mi Jung; Chang, Tae-Ik; Kang, Ea Wha; Kim, Dong Wook; Lim, Beom Jin; Park, Jung Tak; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; An, Seong Yeong; Oh, Hyung Jung; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Jeong, Hyeon Joo; Han, Dae-Suk; Han, Seung Hyeok // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: Proteinuria is a target for renoprotection in kidney diseases. However, optimal level of proteinuria reduction in IgA nephropathy (IgAN) is unknown. Methods: We conducted a retrospective observational study in 500 patients with biopsy-proven IgAN. Time-averaged proteinuria (TA-P) was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics